Wikisage, the free encyclopedia of the second generation, is digital heritage
Amifampridine: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
Amifampridine | Amifampridine | ||
phosphate was granted an Orphan Drug designation by the FDA for MG in September 2016, shortly after receiving a Refusal to File letter from the FDA for its submission for the treatment of congenital myasthenic syndromes and Lambert Eaton myasthenic syndrome (LEMS <ref>https://www.neurologylive.com/clinical-focus/amifampridine-phosphate-shows-success-in-myasthenia-gravis-trial</ref>)<ref>https://www.drugs.com/news/firdapse-amifampridine-approved-rare-autoimmune-disorder-78751.html</ref> | phosphate was granted an Orphan Drug designation by the FDA for MG in September 2016, shortly after receiving a Refusal to File letter from the FDA for its submission for the treatment of congenital myasthenic syndromes and Lambert Eaton myasthenic syndrome (LEMS <ref>https://www.neurologylive.com/clinical-focus/amifampridine-phosphate-shows-success-in-myasthenia-gravis-trial</ref>)<ref>https://www.drugs.com/news/firdapse-amifampridine-approved-rare-autoimmune-disorder-78751.html</ref> | ||
==ATC== | |||
https://www.whocc.no/atc_ddd_index/?code=N07XX05 | |||
==Links== | ==Links== | ||
https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-children-lambert-eaton-myasthenic-syndrome-rare-autoimmune-disorder | https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-children-lambert-eaton-myasthenic-syndrome-rare-autoimmune-disorder | ||
Revision as of 00:18, 7 May 2019
Amifampridine phosphate was granted an Orphan Drug designation by the FDA for MG in September 2016, shortly after receiving a Refusal to File letter from the FDA for its submission for the treatment of congenital myasthenic syndromes and Lambert Eaton myasthenic syndrome (LEMS [1])[2]
ATC
https://www.whocc.no/atc_ddd_index/?code=N07XX05
Links
https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-children-lambert-eaton-myasthenic-syndrome-rare-autoimmune-disorder Drug Trial Snapshot: Firdapse
